# FDA recall D-0120-2020

> **EPI Health, LLC** · Class III · drug recall initiated 2019-08-26.

## Product

minolira (minocycline hydrochloride) extended-release tablets 135 mg* Physician Sample Not for Sale 5 Tablets,  Rx Only, Mfg by: Dr. Reddy's Laboratories Limited, FTO-SEZ, Process Unit-01 Devunipalavalasa Village Srikakulam (District) Andhra Pradesh, INDIA. Manufactured for: EPI Health, LLC 134 Columbus St. Charleston, SC 29403 USA. NDC 71403-102-05.

## Reason for recall

Failed Dissolution Specifications:

## Distribution

Firm recalling only from EPI Field Representatives.

## Key facts

- **Recall number:** D-0120-2020
- **Recalling firm:** EPI Health, LLC
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2019-08-26
- **Report date:** 2019-10-02
- **Termination date:** 2021-08-18

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Charleston, SC, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0120-2020

## Citation

> AI Analytics. FDA recall D-0120-2020. Retrieved 2026-06-25 from https://api.ai-analytics.org/recall/D-0120-2020. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*